Treatment Intensification Strategies and Metabolic Outcomes in Individuals With Type 2 Diabetes on GLP-1 RA Therapy

20251 citationsJournal Article

Authors

Pierpaolo Falcetta · Azienda Usl Toscana Centro

Rita Zilich · Xerox (France)

Fabio Baccetti · Toscana Biomarkers (Italy)

Walter Baronti · Ospedale Misericordia - Grosseto

Davide Masi · Sapienza University of Rome

Lelio Morviducci · Ospedale di Santo Spirito

Nicoletta Musacchio

Abstract

Adding OADs or BI/FRCs to GLP-1 RAs are optimal intensification strategies to provide glycemic control while avoiding weight gain. Target achievement rates are poor in individuals switched to insulin therapy. Therapeutic inertia remains a critical issue in clinical practice.

Topics & Keywords

Diabetes Treatment and Management Pharmacology and Obesity Treatment Metabolism, Diabetes, and Cancer

Publication Details

Published in: The Journal of Clinical Endocrinology & Metabolism

Volume 110, Issue 12, pp. e4101-e4110

DOI: 10.1210/clinem/dgaf229

Field-Weighted Citation Impact: 1.30

Command Palette

Treatment Intensification Strategies and Metabolic Outcomes in Individuals With Type 2 Diabetes on GLP-1 RA Therapy

Authors

Abstract

Topics & Keywords

Publication Details